Поиск

Материалов:
1 005 012

Репозиториев:
30

Авторов:
596 024

Автор

Ключевое слово

Тип статьи

DOI

ORCID

Дополнительно:

Период публикации

Репозиторий

По вашему запросу найдено документов: 73807

Страница 1 из 7381

The increase of cellular antioxidant enzymes activity by metabolic drug eltacin in therapy of elderly patients with ischemic heart disease

Kalinina E.V., Zaslavskaya R.M., Nartsissov Ya.R.

THE DIAGNOSTIC VALUE OF THE SPHYGMOCHRON IN THE EARLY DIAGNOSIS OF PRE-HYPERTENSION AND HYPERTENSION

Cornelissen G., Chibisov S.M., Kharliskaya E.V., Halberg F., Ertueva M., Zaslavskaya R.M., Agarwal R.K.

Merits of assessing the circadian amplitude and acrophase versus a day-night ratio

Dulkova Katarina, Zeman Michal, Cornélissen Germaine, Bada Viliam, Halberg Franz, Zaslavskaya R.M., Chibisov S.M., Kharlickaya E.V., Agarwal R.K.

Feasibility of targeted antiviral therapy for acute respiratory viral infections in the COVID-19 pandemic

Omarova K.G., Balykova L.A., Pshenichnaya N.Yu., Zemskov D.N., Zaslavskaya K.Ya., Taganov A.V., Belyy P.A.

Features of cytokine status dynamics in patients with COVID-19 using Ambervin® Pulmo; [Особенности динамики цитокинового статуса пациентов с COVID-19 на фоне применения препарата Амбервин® Пульмо]

Radaeva O.A., Balykova L.A., Pyataev N.A., Zaslavskaya K.Ya., Kostina Y.A., Eremeev V.V., Taganov A.V., Belyy P.A.

Phase I Pharmacokinetics Study of Oral Administration of Esperavir® (INN: Molnupiravir) (LLC "PROMOMED RUS", Russia)

Komarov T.N., Bagaeva N.S., Karnakova K.K., Zaslavskaya K.Ya., Bely P.A., Shohin I.E.

Simultaneous Determination of Nirmatrelvir and Ritonavir in Human Plasma by HPLC-MS/MS

Komarov T.N., Karnakova P.K., Archakova O.A., Shchelgacheva D.S., Bagaeva N.S., Shohin I.E., Zaslavskaya K.Ya., Bely P.A.

Reciprocal Impact of Molnupiravir and Favipiravir Monocomponents of the Combination Drug on Each Other's Pharmacokinetics in a Phase I Clinical Trial

Komarov T.N., Karnakova K.K., Bagaeva N.S., Archakova O.A., Popova M.O., Shcherbakova V.S., Zaslavskaya K.Ya., Bely P.A., Shohin I.E.

., Popova M. O., Shcherbakova V. S., Zaslavskaya K. Ya., Bely P. A., Shohin I. E., 2024.

Determination of Favipiravir in Human Blood Plasma by HPLC-MS/MS

Komarov T.N., Karpova P.A., Archakova O.A., Shchelgacheva D.S., Karnakova P.K., Bagaeva N.S., Zaslavskaya K.Ya., Bely P.A., Shohin I.E.

., Karnakova P. K., Bagaeva N. S., Zaslavskaya K. Ya., Bely P. A., Shohin I. E., 2023.

STUDY OF LONG-TERM CLINICAL AND PATHOGENETIC EFFECTS OF FAVIPIRAVIR-BASED ANTI-VIRAL DRUG IN PATIENTS WITH METABOLIC SYNDROME IN POST-COVID PERIOD [ИЗУЧЕНИЕ ОТДАЛЕННЫХ КЛИНИКО-ПАТОГЕНЕТИЧЕСКИХ ЭФФЕКТОВ ПРОТИВОВИРУСНОГО ЛЕКАРСТВЕННОГО ПРЕПАРАТА НА ОСНОВЕ ФАВИПИРАВИРА В ПОСТКОВИДНОМ ПЕРИОДЕ У ПАЦИЕНТОВ С МЕТАБОЛИЧЕСКИМ СИНДРОМОМ]

Radaeva O.A., Balykova L.A., Zaslavskaya K.Ya., Taganov A.V., Bely P.A., Kostina Y.A., Negodnova E.V., Mashnina S.V., Bessheinov D.D., Iskandyarova M.S., Eremeev V.V., Chumakov N.M.

Страница 1 из 7381